HOME >> BIOLOGY >> NEWS
Race to halt global amphibian crisis boosted by rediscovery of endangered Colombian frogs

The rediscovery of two frog species feared extinct has made a new Colombian protected area the focal point for efforts to save amphibians from a deadly fungus decimating their populations in Central and South America.

Scientists recently found the two Critically Endangered frogs the Santa Marta harlequin frog (Atelopus laetissimus) and the San Lorenzo harlequin frog (Atelopus nahumae) for the first time in 14 years in the El Dorado Nature Reserve established in March on the northwest slope of the Sierra Nevada de Santa Marta massif, on the Caribbean coast of Colombia.

The reserve is an important home for threatened species, and its protection was a top priority of the Alliance for Zero Extinction a 62-member group of conservation organizations battling global extinctions. In March, alliance members Conservation International (CI) and American Bird Conservancy (ABC) helped Fundacin ProAves of Colombia purchase the 1,600-acre site to protect it as a nature reserve.

Neither of the rediscovered frog species had the deadly fungal disease chytridiomycosis, raising hopes that the species can be saved in the new protected area or through captive breeding. The fungus has been found as close as 40 kilometers (25 miles) away on the other side of the Sierra Nevada mountains, and scientists will study the frogs to learn how they have avoided it.

"It's a race against time to prevent chytridiomycosis from wiping out amphibian populations, but now we have discovered what appear to be healthy populations of these endangered species," said Claude Gascon, CI's senior vice president for regional programs. "Creating the El Dorado Nature Reserve has given Colombia and the world a unique jewel that will prevent the extinction of threatened species of birds and frogs found nowhere else on the planet." El Dorado is the sole breeding ground of the Endangered Santa Marta Parakeet, and home to five threatened amphibians found nowhere else. The site als
'"/>

Contact: Paula Alvarado
palvarado@conservation.org
202-297-0857
Conservation International
6-Jun-2006


Page: 1 2 3

Related biology news :

1. Revolutionary global environment fund announces $50M expansion
2. 1,000-year-old Arctic ponds disappearing due to global warming
3. Desertification: UN experts prescribe global policy overhaul to avoid looming mass migrations
4. Scientists call for global push to advance research in synthetic biology
5. Northern forests less effective than tropical forests in reducing global warming
6. UN issues analysis of global investors sustainable energy gold rush
7. Gannet population under threat from global warming
8. Yale journal examines the global impact of cities
9. Researchers examine carbon capture and storage to combat global warming
10. QUT microgravity tower attracts global scientific community
11. Study warns climate change and deforestation will lead to declines in global bird diversity

Post Your Comments:
(Date:5/20/2015)... 20, 2015 ... announced the addition of the  "5-year ... Recognition Market"  report to their offering.  ... service analyses trends in the iris ... commercial sectors, globally. Despite hardware pricing ...
(Date:5/19/2015)... , May 19, 2015 ... has announced the addition of the  "Genetic ... offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent ... an in-depth analysis of the current and ... of gene-based tests, their working principles and ...
(Date:5/11/2015)... 2015  Synaptics Incorporated (NASDAQ: SYNA ), ... announced the appointment of Wajid Ali ... reporting to Rick Bergman , President and ... Officer, Kathleen Bayless , who announced her ... Ali brings extensive financial management expertise to Synaptics, ...
Breaking Biology News(10 mins):Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Global Genetic Testing Market Outlook 2018 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2
(Date:5/21/2015)...  CytRx Corporation (NASDAQ: CYTR ), a ... today announced positive updated results from its ongoing ... treatment of unresectable glioblastoma multiforme (GBM), a deadly ... is designed to investigate the preliminary efficacy and ... progressed following prior treatment with surgery, radiation and ...
(Date:5/21/2015)... DUBLIN , May 20, 2015 Research ... announced the addition of the "2015 Global ... to their offering. The primary goal ... of flow cytometry instruments and reagents. Key information ... drive the selection of flow cytometers, predominantly used ...
(Date:5/21/2015)... Veolia’s environmental monitoring technology division, Endetec, ... agreement with VWR to distribute TECTA™ B16, an ... 160 years of experience, VWR, a leading global ... production facilities, has cultivated a value proposition delivering ... enable science. Endetec’s TECTA™ B16, combines proven ...
(Date:5/20/2015)... , May 20, 2015 ... presented preliminary data demonstrating the ability of the ... fibrosis (IPF) from other interstitial lung diseases (ILDs) ... the classifier,s potential to help thousands of patients ... ambiguity in IPF diagnosis – a frequent challenge ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Global Survey on Flow Cytometry Adoption Trends 2015 2Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5
Cached News: